What is SAVA's current stock price?

SAVA (Cassava Sciences, Inc.) is currently trading at $1.32 with a market cap of $63.8M.

What sector is Cassava Sciences, Inc. in?

Cassava Sciences, Inc. (SAVA) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

SAVA Cassava Sciences, Inc.

Healthcare

$1.32+2.33%ClosedMarket Cap: $63.8M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

0.93

P/S

0.00

EV/EBITDA

0.29

DCF Value

$1.15

FCF Yield

-141.0%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-99.8%

ROA

-71.9%

ROIC

-120.1%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$0.00	$-10.3M	$—
Q4 null	$0.00	$-12.5M	$—
FY null	$0.00	$-91.0M	$—
Q3 null	$0.00	$-10.8M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All

Anderson Robert Eugene Jrdirector

BuyTue Nov 25

Barry Richarddirector, officer: President & CEO

BuyMon Nov 24

Barry Richarddirector, officer: President & CEO

BuyThu Nov 20

Bir Dawn Carterdirector

SellWed Oct 22

Bir Dawn Carterdirector:

SellWed Oct 22

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

—

Beta

-0.84

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.

Peers